Document Type
Article
Publication Date
2014
Abstract
The scope of cancer treatment in women of childbearing age has changed in the last decade. Fertility preservation is no longer an afterthought but central to multi-disciplinary cancer treatment planning and should be addressed due to the cytotoxic effects of cancer therapy. However, oncology patients present as a unique treatment challenge as the physician must balance the urgency of fertility preservation with the risks of delaying cancer therapy. Controlled ovarian stimulation (COS) is routinely applied in assisted reproductive technology but can be contraindicated in women with estrogen-receptor-positive tumors. This paper reviews some of the challenges to consider when using COS and newer stimulation protocols to minimize risks and optimize outcomes in oncofertility patients.
Repository Citation
Coyne, K.,
Purdy, M.,
O'Leary, K.,
Yaklic, J. L.,
Lindheim, S. R.,
& Appiah, L. A.
(2014). Challenges and Considerations in Optimizing Ovarian Stimulation Protocols in Oncofertility Patients. Frontiers in Public Health, 2, 248.
https://corescholar.libraries.wright.edu/obgyn/130
DOI
10.3389/fpubh.2014.00246
Comments
Copyright © 2014 Coyne, Purdy, O’Leary, Yaklic, Lindheim and Appiah. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.